Kuros Biosciences AG (id:13176 KURN)
22.40 CHF
Opening hours: 09:00 - 17:20 (Central European Standard Time: 11/22/2024 4:10:26 AM)
Exchange closed, opens in 4 hours 49 minutes
About Kuros Biosciences AG
Market Capitalization 934.54M
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold to be implanted in any intervertebral disc space or posterolateral spine level; and Magnetos Flex Matrix, an open matrix bone graft. Its Fibrin-PTH pipeline products comprise KUR-111 and KUR-113 that are in Phase 2b clinical trials for trauma indications; KUR-113 that is in Phase 2a clinical trial for spinal indications. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
| Headquarters (address) |
Wagistrasse 25 Schlieren 8952 Switzerland |
| Phone | 41 44 733 4747 |
| Website | https://www.kuros.ch |
| Employees | 106 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | KURN |
| Exchange | Swiss Stock Exchange |
| Currency | CHF |
| 52 week range | 3.06 - 32.00 |
| Market Capitalization | 934.54M |
| P/E trailing | -59.61 |
| Price/Sale | 17.79 |
| Price/Book | 8.75 |
| Beta | 0.758 |
| EPS | -0.250 |
| EPS Switzerland (ID:153, base:185) | 29.31 |